". @DonnenfeldEric explores risuteganib for DED: Promising treatment with increased TBUT, low staining scores: https://t.co/I2PbX7MCn9 #Ophthalmology #DryEyeDisease #DED #ASCRS #ASCRS2021"

Luminate (risuteganib) - Allegro Ophthalmics

Mar 21, 2022